Prestige Consumer Healthcare Inc. raises its fiscal year 2021 sales projection and maintains its 2% to 3% long-term organic sales outlook as it prepares to leave behind COVID-19-related disruptions and focus on expanding its brands.
“We will begin to lap the effects of COVID-19 that began in the spring of last year while our long-term brand-building strategy continues to set us up for long-term success,” said president and CEO Ron
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?